KevinMD.com: Social media’s leading physician voice
The KevinMD newsletterReal physician voices, twice a weekFree, and one click to unsubscribe.
Subscribe free →
NEWExperts by KevinMDPhysicians and health care experts, by specialty.Anthony GrandelisOB/GYN hospitalistHussain Isma'eelCardiologistChristine KingNurse anesthetistErin J. SilvertoothPsychiatrist and internistFareeha SiddiquiHematologist-oncologistPaul B. JohnsonOculoplastic surgeonPaul HainPediatricianSanjeev SharmaEmergency physicianDiane W. ShannonPrimary care physicianBill KinnardPulmonologistOren FassOphthalmologistJeffrey JunigPsychiatristAngelika LuehrsConsultant psychiatristVikas PatelEmergency physicianShveta GuptaHematology physicianSarah WhiteNurse practitionerPaul ColettaHealth care CEORao M. UppuEnvironmental toxicologistAnne BaskakovaDigital health leaderAnna EstrinFashion journalistBrowse experts
Amir Friedman, MD

Enhanced author page

Amir Friedman, MD

A pain physician, physician-scientist, and investigator with 25 years of clinical experience.

Listed in Experts by KevinMD

Connect on LinkedIn

About

Amir Friedman is a pain physician, physician-scientist, and investigator with 25 years of clinical experience and more than 10,000 patients treated. He trained in surgery, anesthesiology, critical care, and pain medicine at the University of Southern California and the University of California, Los Angeles.

His work focuses on chronic pain, neuromodulation, regenerative medicine, longevity, men's health, and emerging approaches to chronic disease. He writes about neuroscience, AI-enabled medicine, and the challenge of translating innovation into meaningful patient care.

Friedman also applies his experience in complex chronic illness and care delivery through his work with Broadway Community Care Centers in California, advancing integrated behavioral health care models designed to improve access, coordination, and outcomes for underserved communities. He can be found on LinkedIn.

Latest articles

Drugs and prescribing

The nociplastic pain question new pain therapies avoid

Systematic review data puts the prevalence of central sensitization features among knee osteoarthritis patients at approximately 36 percent by validated instrument. More than one in three patients carrying an orthopedic diagnosis you trust, presenting with pain that structural intervention may…

Systematic review data puts the prevalence of central sensitization features among knee osteoarthritis patients at approximately 36 percent by validated instrument. More than one in three patients carrying an orthopedic diagnosis you trust, presenting with pain that structural intervention may only partially address. The joint pathology on the imaging is real. The dominant pain mechanism is incompletely characterized.

In my last piece, I argued that glucagon-like peptide-1 (GLP-1) pharmacology and neurotechnology …

Read more…

The nociplastic pain question new pain therapies avoid

Conditions and diseases

GLP-1s and neurotech are colliding over chronic pain

Fifty million Americans wake up in chronic pain every day. Not soreness. Not the dull ache of a hard week. Pain that has dismantled careers, ended marriages, and driven people, my patients, over 25 years, to suicide, overdose, and a…

Fifty million Americans wake up in chronic pain every day. Not soreness. Not the dull ache of a hard week. Pain that has dismantled careers, ended marriages, and driven people, my patients, over 25 years, to suicide, overdose, and a slow erasure of self. I trained at USC and UCLA, spent three decades in interventional pain management, and I can tell you with clinical certainty: the system we built to …

Read more…

GLP-1s and neurotech are colliding over chronic pain

Real physician voices, twice a week

Free, and one click to unsubscribe.

No spam. We never share your email.